Humanized immune system (HIS) mice provide researchers with a unique opportunity to study human immune responses in a living organism. Developed to address the lack of suitable in vivo models for ...
GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to ...
NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
UD researchers study how protein coatings influence nanoparticles' ability to avoid immune clearance and reach their ...
Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...
Nanomedicine uses ultra-small particles to deliver drugs directly to the tissues and cells that need them, improving ...
Since the development of the super immunodeficient CIEA NOG mouse® in the early 2000s enabled improved humanized immune system (HIS) mice, HIS models have been widely adopted in immuno-oncology ...
Desmoplastic nodular medulloblastoma: A National Cancer Database analysis of patient demographics and survival. A phase 1 study to evaluate the safety and tolerability of BXQ-350, a novel sphingolipid ...
TipRanks on MSN
NanoViricides says NV-387 shows ‘strong antiviral activity’
NanoViricides (NNVC) announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in cell culture studies as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results